SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Today, BayBio submitted a brief as amicus curiae (friend of the court) in the Supreme Court of the United States in the case of Matrixx Initiatives Inc. v. James Siracusano. The case concerns whether the failure to disclose non-statistically significant adverse event data can give rise to fraud claims under federal securities laws.
